2160 — MicroPort CardioFlow Medtech Balance Sheet
0.000.00%
- HK$3.02bn
- HK$3.43bn
- $57.04m
Annual balance sheet for MicroPort CardioFlow Medtech, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | R2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | PRESS | PRESS |
| Standards: | IFRS | IFRS | IFRS | — | — |
| Status: | fx Final | fx Final | fx Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 378 | 301 | 250 | 189 | 179 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 15.5 | 7.65 | 18.7 | 25 | 107 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 409 | 329 | 288 | 233 | 373 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 42.1 | 35 | 27.8 | 70.4 | 102 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 529 | 435 | 363 | 372 | 670 |
| Accounts Payable | |||||
| Payable / Accrued | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 25.9 | 25.7 | 27.3 | 60.4 | 148 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 41.8 | 35.9 | 34.1 | 68 | 413 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 487 | 399 | 329 | 304 | 256 |
| Total Liabilities & Shareholders' Equity | 529 | 435 | 363 | 372 | 670 |
| Total Common Shares Outstanding |